台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    79.9
  • 漲跌
    ▲0.2
  • 漲幅
    +0.25%
  • 成交量
    287
  • 產業
    上櫃 生技醫療類股
  • 315人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-富邦-景美 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-景美 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/09/15991.6100.0090.5093,6070.25%
2023/09/14390.67390.6391.8003,6000.00%
2023/09/1200.00292.4092.20-23,582-0.06%
2023/09/115.293.50592.4092.100.23,5930.01%
2023/09/08992.83195.0093.7083,5490.23%
2023/09/071497.341597.2096.80-13,455-0.03%
2023/09/063106.673104.67107.5003,3190.00%
2023/09/0514107.649113.78106.5053,2510.15%
2023/09/0400.005118.20118.00-53,146-0.16%
2023/09/011119.001116.50118.0003,1490.00%
2023/08/312117.753118.50118.50-13,182-0.03%
2023/08/302114.506117.99116.50-43,136-0.13%
2023/08/2900.005108.00109.50-53,056-0.16%
2023/08/2812107.1700.00107.50123,1460.38%
2023/08/251108.0000.00108.5013,1990.03%
2023/08/242106.5000.00107.5023,1740.06%
2023/08/234108.133113.17107.5013,1500.03%
2023/08/222111.503112.50111.50-13,106-0.03%
2023/08/213110.679109.84112.50-63,027-0.20%
2023/08/187104.148102.88103.00-12,908-0.03%
2023/08/17599.34598.8099.6002,8590.00%
2023/08/14394.0700.0093.5032,9730.10%
2023/08/10398.17198.4095.9023,1580.06%
2023/08/091899.25999.4399.2093,2720.28%
2023/08/08295.00195.5095.0013,5650.03%
2023/08/07195.0000.0094.4013,6490.03%
2023/08/02192.40192.4092.2003,6840.00%
2023/08/0100.00095.0094.8003,6880.00%
2023/07/31194.8000.0094.0013,7200.03%
2023/07/28294.40394.5094.50-13,797-0.03%
2023/07/26198.7000.0097.1013,8650.03%
2023/07/251100.5000.00102.0013,8860.03%
2023/07/24298.102101.25100.0003,8670.00%
2023/07/201100.50598.5698.50-44,489-0.09%
2023/07/198102.6910101.30100.00-24,546-0.04%
2023/07/18598.60696.5596.50-14,711-0.02%
2023/07/17697.73198.2097.9055,0120.10%
2023/07/14394.90597.2097.10-25,242-0.04%
2023/07/13193.60492.8892.50-35,379-0.06%
2023/07/12294.1000.0093.4025,4250.04%
2023/07/11195.0000.0095.0015,5420.02%
2023/07/10396.3300.0096.4035,8380.05%
2023/07/07599.3600.0098.4055,9870.08%
2023/07/061102.0000.00100.5016,0660.02%
2023/07/052103.2500.00103.5026,0840.03%
2023/07/0400.0013102.69102.50-136,199-0.21%
2023/07/033101.333102.33102.5006,2030.00%
2023/06/3023107.0225105.62106.00-26,188-0.03%
2023/06/297104.142106.26108.0056,0630.08%
2023/06/26195.0000.0094.2016,3770.02%
2023/06/21295.5000.0094.9026,6180.03%
2023/06/20296.8000.0096.0026,8140.03%
2023/06/19498.03295.5097.6026,8170.03%
2023/06/161099.09797.7196.6036,8190.04%
2023/06/1500.001198.8598.50-116,795-0.16%
2023/06/141101.0000.00100.5016,7560.01%
2023/06/121103.5012101.75102.50-116,731-0.16%
2023/06/091106.0000.00105.5016,6870.01%
2023/06/081107.0000.00107.5016,6920.01%
2023/06/075107.8000.00107.5056,6700.07%
2023/06/068109.0018109.58108.50-106,644-0.15%
2023/06/050.1118.004117.75116.50-46,555-0.06%
2023/06/026117.674116.63115.5026,5130.03%
2023/06/0120117.5323117.72117.00-36,449-0.05%
2023/05/3100.002114.50112.50-26,368-0.03%
2023/05/309111.3900.00109.5096,3240.14%
2023/05/295110.5000.00109.5056,3810.08%
2023/05/261106.5000.00106.5016,5360.02%
2023/05/244110.8815109.33113.00-116,603-0.17%
2023/05/221112.503111.00111.50-26,525-0.03%
2023/05/1900.004107.50107.00-46,476-0.06%
2023/05/1800.001112.50112.50-16,413-0.02%
2023/05/172113.002112.00112.0006,3640.00%
2023/05/1625108.6222109.36111.0036,2540.05%
2023/05/1546104.5445104.96106.5016,1480.02%
2023/05/1229107.9111104.41105.00185,9910.30%
2023/05/111115.0024121.50113.50-235,643-0.41%
2023/05/105124.0000.00126.0055,5610.09%
2023/05/0900.001125.00124.00-15,545-0.02%
2023/05/081131.0000.00132.0015,5000.02%
2023/05/0512134.8818131.09130.50-65,485-0.11%
2023/05/0419127.406128.75132.00135,4460.24%
2023/05/032125.5012126.00121.50-105,357-0.19%
2023/05/022123.0011.1122.99123.00-9.15,308-0.17%
2023/04/285118.002117.50118.5035,2570.06%
2023/04/2616108.8120.3111.91112.50-4.35,183-0.08%
2023/04/2511114.192114.25112.0094,8680.19%
2023/04/2400.001113.50111.50-14,469-0.02%
2023/04/217.2113.8337110.35112.50-29.94,367-0.68%
2023/04/202114.502116.00112.5004,1390.00%
2023/04/1917108.5017104.68118.0003,8130.00%
2023/04/188108.3100.00107.5083,5480.23%
2023/04/173.1105.483104.00104.000.13,3830.00%
2023/04/1411.2103.162106.00103.009.23,3050.28%
2023/04/133108.6711107.09108.00-83,180-0.25%
2023/04/121097.793104.50104.5072,8660.24%
2023/04/111393.531193.4195.0022,6830.07%
2023/04/10491.151389.8090.70-92,597-0.35%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章